Valirx (VAL)

 0.45p
   
  • Change Today:
      0.000p
  • 52 Week High: 0.77
  • 52 Week Low: 0.34
  • Currency: UK Pounds
  • Shares Issued: 1,711.18m
  • Volume: 1,975,552
  • Market Cap: £7.70m
  • RiskGrade: 273

Latest ShareCast News

ValiRx granted patent in Australia for VAL201 targeting cancer

Date: Thursday 25 Apr 2013

ValiRx has been granted a patent for its lead therapeutic compound VAL201 for the treatment of breast, prostate, breast and ovarian cancer in Australia.

Valirx Regulatory News

New Patent Granted 25-Apr-2013 07:00 RNS
Result of AGM 22-Apr-2013 11:52 RNS
Final Results 28-Mar-2013 07:01 RNS
Appointment of Medical Monitoring Officer 23-Jan-2013 07:00 RNS
Total Voting Rights 31-Dec-2012 07:00 RNS

Valirx News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 0.45p
Change Today 0.000p
% Change 0.00 %
52 Week High 0.77
52 Week Low 0.34
Volume 1,975,552
Shares Issued 1,711.18m
Market Cap £7.70m
RiskGrade 273

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.51% below the market average12.51% below the market average12.51% below the market average12.51% below the market average12.51% below the market average
47.83% above the sector average47.83% above the sector average47.83% above the sector average47.83% above the sector average47.83% above the sector average
Price Trend
17.08% below the market average17.08% below the market average17.08% below the market average17.08% below the market average17.08% below the market average
16% below the sector average16% below the sector average16% below the sector average16% below the sector average16% below the sector average
Income Not Available
Growth
18.74% above the market average18.74% above the market average18.74% above the market average18.74% above the market average18.74% above the market average
23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average

Valirx Dividends

No dividends found

Trades for 21-May-2013

Time Volume / Share Price
12:45 24,323 @ 0.44p
12:20 200,538 @ 0.46p
12:09 226,923 @ 0.44p
12:07 107,769 @ 0.46p
10:37 100,000 @ 0.46p

Valirx Key Personnel

CFO Gerald Desler
CEO Satu Vainikka

Top of Page